Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro

Antiviral Research

Volumn 83, Issue 2, 2009, Pages 186-190

  Wang, Gui Feng ^a   Shi, Li Ping ^a   Ren, Yu Dan ^a   Liu, Qun Fang ^a   Liu, Hou Fu ^a   Zhang, Ru Jun ^a   Li, Zhuang ^c   Zhu, Feng Hua ^a   He, Pei Lan ^a   Tang, Wei ^a   Tao, Pei Zhen ^c   Li, Chuan ^a   Zhao, Wei Min ^a   Zuo, Jian Ping ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Caffeic acid; Chlorogenic acid; Coffee crude extracts; HBV; Quinic acid

Indexed keywords

CAFFEIC ACID; CHLOROGENIC ACID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PLACEBO; QUINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DUCK; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CAFFEIC ACIDS; CELL LINE; CHLOROGENIC ACID; DUCKS; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; HUMANS; INHIBITORY CONCENTRATION 50; QUINIC ACID; SERUM; VIRUS REPLICATION;

DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS;

EID: 67349165118     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.05.002     Document Type: Article

References (33)

1. An R.B., Sohn D.H., Jeong G.S., and Kim Y.C. In vitro hepatoprotective compounds from Suaeda glauca. Arch. Pharm. Res. 31 (2008) 594-597
2. Bravi F., Bosetti C., Tavani A., Bagnardi V., Gallus S., Negri E., Franceschi S., and La Vecchia C. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46 (2007) 430-435
3. Buti M., and Esteban R. Drugs in development for hepatitis B. Drugs 65 (2005) 1451-1460
4. Center of Disease Control and Prevention, 2006. Prevalence of chronic infection with hepatitis B virus, by country. Available at http://wwwn.cdc.gov/travel/yellowBookCh4-HepB.aspx.
5. Chattopadhyay D., and Naik T.N. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev. Med. Chem. 7 (2007) 275-301
6. Chiang L.C., Chiang W., Chang M.Y., Ng L.T., and Lin C.C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55 (2002) 53-62
7. Clifford M.N. Chlorogenic acids and other cinnamates-nature, occurence and dietary burden. J. Sci. Food Agric. 79 (1999) 362-372
8. Corrao G., Zambon A., Bagnardi V., D'Amicis A., and Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol. 11 (2001) 458-465
9. Cos P., Maes L., Vanden Berghe D., Hermans N., Pieters L., and Vlietinck A. Plant substances as anti-HIV agents selected according to their putative mechanism of action. J. Nat. Prod. 67 (2004) 284-293
10. Cos P., Maes L., Vlietinck A., and Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection-an update (1998-2007). Planta Med. 74 (2008) 1323-1337
11. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., and Ding M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280 (2005) 27888-27895
12. Han Y.Q., Huang Z.M., Yang X.B., Liu H.Z., and Wu G.X. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. J. Ethnopharmacol. 118 (2008) 148-153
13. Helbig B., Kloecking R., and Wutzler P. Anti-herpes simplex virus type 1 activity of humic acid-like polymers and their o-diphenolic starting compounds. Antivir. Chem. Chemother. 8 (1997) 265-273
14. Hung T.M., Na M., Thuong P.T., Su N.D., Sok D., Song K.S., Seong Y.H., and Bae K. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J. Ethnopharmacol. 108 (2006) 188-192
15. Jassim S.A., and Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 95 (2003) 412-427
16. Khan M.T., Ather A., Thompson K.D., and Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res. 67 (2005) 107-119
17. Li Y., But P.P., and Ooi V.E. Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin. Antiviral Res. 68 (2005) 1-9
18. Li Y.F., Wang G.F., He P.L., Huang W.G., Zhu F.H., Gao H.J., Tang W., Luo Y., Feng C.L., Shi L.P., Ren Y.D., Lu W., and Zuo J.P. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives. J. Med. Chem. 49 (2006) 4790-4794
19. McDougall B., King P.J., Wu B.W., Hostomsky Z., Reinecke M.G., and Robinson Jr. W.E. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob. Agents Chemother. 42 (1998) 140-146
20. Miura D., Miura Y., and Yagasaki K. Effect of apple polyphenol extract on hepatoma proliferation and invasion in culture and on tumor growth, metastasis, and abnormal lipoprotein profiles in hepatoma-bearing rats. Biosci. Biotechnol. Biochem. 71 (2007) 2743-2750
21. Naithani R., Huma L.C., Holland L.E., Shukla D., McCormick D.L., Mehta R.G., and Moriarty R.M. Antiviral activity of phytochemicals: a comprehensive review. Mini Rev. Med. Chem. 8 (2008) 1106-1133
22. Namba T., and Matsuse T. A historical study of coffee in Japanese and Asian countries: focusing the medicinal uses in Asian traditional medicines. Yakushigaku Zasshi 37 (2002) 65-75
23. Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Lett. 277 (2009) 121-125
24. Pavlica S., and Gebhardt R. Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Radic. Res. 39 (2005) 1377-1390
25. Ruhl C.E., and Everhart J.E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129 (2005) 1928-1936
26. Sells M.A., Chen M.L., and Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 1005-1009
27. Shimazu T., Tsubono Y., Kuriyama S., Ohmori K., Koizumi Y., Nishino Y., Shibuya D., and Tsuji I. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int. J. Cancer 116 (2005) 150-154
28. Shimizu M., Yoshimi N., Yamada Y., Matsunaga K., Kawabata K., Hara A., Moriwaki H., and Mori H. Suppressive effects of chlorogenic acid on N-methyl-N-nitrosourea-induced glandular stomach carcinogenesis in male F344 rats. J. Toxicol. Sci. 24 (1999) 433-439
29. Staprans S., Loeb D.D., and Ganem D. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J. Virol. 65 (1991) 1255-1262
30. Tamura H., Akioka T., Ueno K., Chujyo T., Okazaki K., King P.J., and Robinson Jr. W.E. Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves. Mol. Nutr. Food Res. 50 (2006) 396-400
31. United States Department of Agriculture, 2007. Tropital products: world markets and trade. Available at http://www.fas.usda.gov/htp/tropical/2007/June%202007/June%20Tropical.pdf.
32. Utsunomiya H., Ichinose M., Uozaki M., Tsujimoto K., Yamasaki H., and Koyama A.H. Antiviral activities of coffee extracts in vitro. Food Chem. Toxicol. 46 (2008) 1919-1924
33. Wu Q.L., Fu Y.F., Zhou W.L., Wang J.X., Feng Y.H., Liu J., Xu J.Y., He P.L., Zhou R., Tang W., Wang G.F., Zhou Y., Yang Y.F., Ding J., Li X.Y., Chen X.R., Yuan C., Lawson B.R., and Zuo J.P. Inhibition of S-adenosyl-l-homocysteine hydrolase induces immunosuppression. J. Pharmacol. Exp. Ther. 313 (2005) 705-711